ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,458Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 117

$558K Total Retail Price of All Prescriptions

Rank: 38 out of 117

280 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 280 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

31% of this provider’s 280 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

0% of this provider’s 9,656 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 460 412 S3 1 3
NAMENDA 395 370 2 7
LEVOTHYROXINE SODIUM 346 330 3 1
DONEPEZIL HCL 333 329 4 10
LISINOPRIL 314 310 5 6
MIRTAZAPINE 296 292 6 14
FUROSEMIDE 283 262 7 4
POTASSIUM CHLORIDE 282 268 8 11
QUETIAPINE FUMARATE 276 267 9 20
SIMVASTATIN 265 249 10 2
GABAPENTIN 257 233 11 12
WARFARIN SODIUM 237 209 12 13
AMLODIPINE BESYLATE 232 232 13 5
METOPROLOL TARTRATE 224 223 14 8
CITALOPRAM HBR 222 199 15 18
OMEPRAZOLE 206 194 16 9
ESCITALOPRAM OXALATE 168 166 17 29
DIVALPROEX SODIUM 132 110 18 37
PERMETHRIN 125 123 19 221
SERTRALINE HCL 111 111 20 16
TRAMADOL HCL 106 104 21 19
PANTOPRAZOLE SODIUM 103 102 22 39
CLOPIDOGREL 102 102 23 30
ZOLPIDEM TARTRATE 100 86 24 24
METFORMIN HCL 97 94 25 15
CARVEDILOL 95 95 26 22
SEROQUEL 87 87 27 57
TRAZODONE HCL 85 83 28 23
METOPROLOL SUCCINATE 84 82 29 17
DIOVAN 80 80 30 38
RANITIDINE HCL 76 69 31 43
LANTUS 75 66 32 25
NOVOLIN R 71 61 33 40
CYMBALTA 70 67 34 27
PLAVIX 69 69 35 41
RISPERIDONE 68 68 36 35
BACLOFEN 67 55 37 74
ATENOLOL 64 63 38 42
PREDNISONE 63 58 39 47
ABILIFY 60 35 40 75
TRIAMCINOLONE ACETONIDE 59 59 41 145
LEVOFLOXACIN 58 49 42 55
KLOR-CON M20 56 51 43 54
LEVETIRACETAM 56 36 43 46
LEXAPRO 56 53 43 86
DIGOXIN 55 53 46 45
METOCLOPRAMIDE HCL 54 26 47 91
ALENDRONATE SODIUM 51 51 48 26
ALBUTEROL SULFATE 50 50 49 68
SINGULAIR 50 45 49 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.